A Phase IIIb, Multicenter, Randomized, Double Masked, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab in Subjects With Subfoveal Choroidal Neovascularization (CNV) With or Without Classic CNV Secondary to Age Related Macular Degeneration
收藏Mendeley Data2024-01-31 更新2024-06-28 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005668/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a phase III, multicenter, randomized, double masked, sham injection-controlled study of the efficacy and safety of intravitreally administered ranibizumab in subjects with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
创建时间：
2024-01-31
